-
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
prnasia
December 07, 2021
The National Comprehensive Cancer Network (NCCN®)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used resource for enabling discussion and treatment of distress as part of routine care...
-
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...
-
Late cancer diagnoses rise as NHS struggles with COVID-19
PharmaTimes
December 01, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic...
-
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients
prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...
-
Trillium Therapeutics Receives Final Court Order Approving Arrangement
FirstWordPharma
October 29, 2021
Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce that...
-
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
prnasia
October 25, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition.
-
World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025
prnewswire
October 13, 2021
The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report...
-
AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials
prnasia
September 28, 2021
Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates...
-
Blood test can detect more than 50 types of cancer
pharmatimes
June 28, 2021
Researchers have developed a blood test able detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, including those aged over 50 with no symptoms.
-
ARPA-H: Biden’s proposed government health agency hopes to cure cancer
pharmaceutical-technology
June 09, 2021
The White House has requested $6.5bn of federal funding for an agency to investigate treatments for cancer and other diseases.